Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

0.81 

0.01 1.5%

as of Nov 08 '18

52 Week Range:

0.48 0.87


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, export, and sale of single-use medical devices under the Jierui and Wego Ortho brands in the People's Republic of China and internationally. The company operates through three divisions: Single Use Medical Device Products, Orthopaedic Products, and Others. It offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregator consumables, and blood sampling products; pre-filled syringes for pre-pack medication; and medical needles, which primarily include intravenous and syringe needles, intravenous catheter needles, wound management needles, blood sampling needles, and irregular needles. The company also provides orthopedic materials and instruments, such as trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment comprising puncture needles, dialyzers, and related consumables, as well as extracorporeal blood circuits for blood purification sets. In addition, it engages in the wholesale, purchase, sale, and retail of disposable sterile medical devices; and sells computer software. Further, the company provides logistics and storage services; asset management and enterprise consulting services; finance leasing and factoring services; and enterprise management advisory services. Additionally, it offers industrial automatic equipment and parts; hemo-dialysis equipment; medical PVC granules, plastic packing bags, and carton boxes; molds; surgical devices and other disposal medical products; and implantation materials and artificial organs. The company serves hospitals, blood stations, and other medical units; and distributors. The company was founded in 2000 and is based in Weihai, the People's Republic of China. Shandong Weigao Group Medical Polymer Company Limited is a subsidiary of Weigao Holding Company Limited.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 0.02
0.03
0.06
0.08
0.14
0.23
0.25
0.28
0.32
0.34
0.35
growth rate 50.0% 100.0% 33.3% 75.0% 64.3% 8.7% 12.0% 14.3% 6.3% 2.9%
Earnings BIT 1,064.93
1,124.42
1,284.59
1,106.00
1,375.60
growth rate 5.6% 14.2% -13.9% 24.4%
Avg.PE 19.50
18.06
8.20
growth rate -7.4% -54.6%
ROA 17.44
17.60
17.38
18.58
49.38
10.04
3.56
9.29
8.70
7.56
10.63
growth rate 0.9% -1.3% 6.9% 165.8% -79.7% -64.5% 161.0% -6.4% -13.1% 40.6%
ROE 30.41
25.36
23.41
24.34
58.54
11.65
4.32
11.49
10.85
9.82
13.73
growth rate -16.6% -7.7% 4.0% 140.5% -80.1% -62.9% 166.0% -5.6% -9.5% 39.8%
ROIC 22.40
23.84
22.15
23.65
57.59
11.47
4.22
10.83
9.98
9.02
12.32
growth rate 6.4% -7.1% 6.8% 143.5% -80.1% -63.2% 156.6% -7.9% -9.6% 36.6%
Cur. Ratio 1.98
2.78
2.31
2.42
3.58
2.53
3.00
3.39
3.78
3.23
3.94
growth rate 40.4% -16.9% 4.8% 47.9% -29.3% 18.6% 13.0% 11.5% -14.6% 22.0%
Quick Ratio 1.52
2.35
1.82
2.00
3.05
1.84
2.47
2.79
3.27
2.78
3.41
growth rate 54.6% -22.6% 9.9% 52.5% -39.7% 34.2% 13.0% 17.2% -15.0% 22.7%
Leverage 1.61
1.35
1.34
1.28
1.14
1.18
1.25
1.23
1.27
1.33
1.26
growth rate -16.2% -0.7% -4.5% -10.9% 3.5% 5.9% -1.6% 3.3% 4.7% -5.3%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 1,531.00
2,122.43
2,801.83
2,814.39
3,555.72
4,239.53
growth rate 38.6% 32.0% 0.5% 26.3% 19.2%
Acct.Payable 922.00
990.26
674.54
478.65
594.15
651.77
growth rate 7.4% -31.9% -29.0% 24.1% 9.7%
Cur.Assets 3,871.00
6,253.42
6,799.04
7,526.28
8,682.27
9,056.12
growth rate 61.6% 8.7% 10.7% 15.4% 4.3%
Total Assets 10,479.00
11,288.10
12,070.11
13,519.25
15,756.31
16,782.86
growth rate 7.7% 6.9% 12.0% 16.6% 6.5%
Cash 1,298.00
2,975.62
2,786.09
3,712.15
4,071.89
3,784.54
growth rate 129.3% -6.4% 33.2% 9.7% -7.1%
Inventory 830.00
866.36
914.52
850.59
915.59
804.61
growth rate 4.4% 5.6% -7.0% 7.6% -12.1%
Cur.Liabilities 1,530.00
2,082.30
2,002.93
2,001.64
2,683.92
2,299.65
growth rate 36.1% -3.8% -0.1% 34.1% -14.3%
Liabilities 1,558.00
2,225.16
2,190.52
2,732.42
3,551.05
3,138.75
growth rate 42.8% -1.6% 24.7% 30.0% -11.6%
LT Debt 99.70
149.10
649.20
791.80
804.27
growth rate 49.6% 335.4% 22.0% 1.6%
Equity 9,040.35
9,847.91
10,658.18
11,866.58
13,338.17
growth rate 8.9% 8.2% 11.3% 12.4%
Common Shares 3,946.00
3,994.00
8,610.00
4,305.00
4,418.00
4,476.00
4,476.00
4,476.00
4,478.00
4,478.00
4,483.00
growth rate 1.2% 115.6% -50.0% 2.6% 1.3% 0.0% 0.0% 0.0% 0.0% 0.1%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 924.00
948.86
731.72
1,113.51
619.67
1,428.80
growth rate 2.7% -22.9% 52.2% -44.4% 130.6%
Cash Dividends 277.54
277.54
331.25
252.52
490.56
growth rate 0.0% 19.4% -23.8% 94.3%
Cash From OA 806.00
720.17
711.22
1,052.77
1,053.14
1,267.01
growth rate -10.7% -1.2% 48.0% 0.0% 20.3%
FCF per Share 0.01
-0.01
-0.01
-0.01
0.02
growth rate -100.0% 0.0% 0.0% 100.0%
FCF 51.00
235.00
161.00
184.00
-515.00
-218.00
-294.00
-39.00
-78.00
414.00
-246.00
growth rate 360.8% -31.5% 14.3% -100.0% 0.0% 0.0% 0.0% 0.0% 100.0% -100.0%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 3,689.00
4,613.31
5,277.83
5,918.93
5,619.84
6,292.64
growth rate 25.1% 14.4% 12.2% -5.1% 12.0%
Op.Income 996.00
1,064.93
1,124.42
1,284.59
1,106.00
1,375.60
growth rate 6.9% 5.6% 14.2% -13.9% 24.4%
IBT 544.15
1,275.66
1,335.51
1,186.68
1,527.56
growth rate 134.4% 4.7% -11.1% 28.7%
Net Income 996.00
387.98
1,084.95
1,112.74
1,105.93
1,729.92
growth rate -61.1% 179.6% 2.6% -0.6% 56.4%
EPS 0.08
0.12
0.07
0.19
0.78
0.22
0.09
0.24
0.25
0.25
0.39
growth rate 50.0% -41.7% 171.4% 310.5% -71.8% -59.1% 166.7% 4.2% 0.0% 56.0%
Gross Profit 2,112.00
2,726.87
3,104.31
3,515.56
3,577.75
3,991.11
growth rate 29.1% 13.8% 13.3% 1.8% 11.6%
R&D 208.92
238.10
292.66
266.04
273.83
growth rate 14.0% 22.9% -9.1% 2.9%

Quarterly Statements

Item Name Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Earnings BIT 377.06
452.97
452.97
growth rate 6.3% 0.0%
Balance Sheet Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Acct.Receivable 3,885.92
4,239.53
4,239.53
4,581.25
4,581.25
growth rate 9.1% 0.0% 8.1% 0.0%
Acct.Payable 636.79
651.77
651.77
853.55
853.55
growth rate 2.4% 0.0% 31.0% 0.0%
Cur.Assets 8,697.90
9,056.12
9,056.12
9,109.13
9,109.13
growth rate 4.1% 0.0% 0.6% 0.0%
Total Assets 16,450.30
16,782.86
16,782.86
22,598.06
22,598.06
growth rate 2.0% 0.0% 34.7% 0.0%
Cash 3,440.00
3,784.54
3,784.54
2,964.23
2,964.23
growth rate 10.0% 0.0% -21.7% 0.0%
Inventory 966.79
804.61
804.61
1,009.94
1,009.94
growth rate -16.8% 0.0% 25.5% 0.0%
Cur.Liabilities 2,858.37
2,299.65
2,299.65
3,151.04
3,151.04
growth rate -19.6% 0.0% 37.0% 0.0%
Liabilities 3,736.95
3,138.75
3,138.75
8,146.59
8,146.59
growth rate -16.0% 0.0% 159.6% 0.0%
LT Debt 813.23
804.27
804.27
4,636.04
4,636.04
growth rate -1.1% 0.0% 476.4% 0.0%
Equity 12,319.20
13,338.17
13,338.17
13,839.10
13,839.10
growth rate 8.3% 0.0% 3.8% 0.0%
Common Shares 452.23
452.23
452.23
452.23
452.23
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Capital Expenditures
growth rate
Cash Dividends 102.96
102.96
102.96
102.96
102.96
growth rate 0.0% 0.0% 0.0% 0.0%
Cash From OA 206.92
480.10
480.10
480.10
480.10
growth rate 132.0% 0.0% 0.0% 0.0%
FCF
growth rate
Income Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Sales 1,787.06
2,075.25
2,075.25
growth rate 5.1% 0.0%
Op.Income 377.06
452.97
452.97
452.97
452.97
growth rate 20.1% 0.0% 0.0% 0.0%
IBT 403.39
386.10
386.10
386.10
386.10
growth rate -4.3% 0.0% 0.0% 0.0%
Net Income 325.07
325.03
325.03
growth rate 0.0% 0.0%
Gross Profit 1,077.04
1,306.52
1,306.52
growth rate 6.7% 0.0%
R&D 74.01
70.85
70.85
70.85
70.85
growth rate -4.3% 0.0% 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (65.64)

YOY Growth Grade:

C (51.85)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 13.69 13.73
EPS / Growth 0.06

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.3% 11.3% 11.3%
Future PE 0.01 12.09 12.09
Future EPS 0.17 0.17 0.17
Value Price
MOS %
0.00
-100.0%
0.51
-36.6%
0.51
-36.6%
MOS Price 0.00 0.26 0.26
IRT 8.15 8.15 8.15

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.